Kinase Therapeutics: Pipeline Assessment and Commercial Prospects Report Now Available on ReportsandReports
The number of kinase inhibitors entering clinical development has increased significantly in recent years. In addition to major pharmaceutical and biotech companies, an increasing number of emerging companies are focusing on their development.
View full press release